Yazhen Qin

发表

Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling Pathway.

Xiao-hui Zhang, Lanping Xu, Xiao-jun Huang, 2017, Stem cells and development.

The differences and correlations of BCR‐ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia

Ya-Zhen Qin, Q. Jiang, B. Jiang, 2012, American journal of hematology.

Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.

Ya-Zhen Qin, Yu Wang, Lanping Xu, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation.

Yan-rong Liu, Yu Wang, Lanping Xu, 2012, Blood.

Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia

Ya-Zhen Qin, Yan-rong Liu, Yu-Hong Chen, 2012, Journal of Hematology & Oncology.

Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements

Qian Jiang, Q. Jiang, Xiao-jun Huang, 2017, Annals of Hematology.

Leukemia-propagating cells demonstrate distinctive gene expression profiles compared with other cell fractions from patients with de novo Philadelphia chromosome-positive ALL

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, Annals of Hematology.

DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia

Jiamin Zhang, Yanmei Xu, R. Gale, 2020, British journal of haematology.

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2010, Annals of Hematology.

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Yan Liu, Hao Jiang, Q. Jiang, 2008, Acta Haematologica.

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2011, Blood.

Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2010, Annals of Hematology.

High frequency of IKZF1 deletions in Chinese adult patients with acute lymphoblastic leukemia detected by multiplex real-time quantitative PCR

Li-xin Wu, Yan-rong Liu, Xiao-jun Huang, 2017 .

Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo

Yan-rong Liu, Xiao-jun Huang, G. Ruan, 2008, Apoptosis.

B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature.

Hao Jiang, Y. Lai, Honghu Zhu, 2016, Oncology letters.

Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation

R. Gale, Ya-Zhen Qin, Hao Jiang, 2016, Chinese journal of cancer.

Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2014, Leukemia research.

Patients with Philadelphia-positive leukemia with Y253H or F359V mutation have a high risk of developing new mutations in the setting of dasatinib resistance

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2015, Leukemia & lymphoma.

The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB–MYH11‐positive acute myeloid leukaemia indicates poor prognosis

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2020, British journal of haematology.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2015, Leukemia & lymphoma.

Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2021, Annals of Hematology.

Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients

Ya-Zhen Qin, Yan-rong Liu, Wen-Min Chen, 2021, Pediatric hematology and oncology.

CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.

Ya-Zhen Qin, Yan-rong Liu, Xiao-jun Huang, 2016, Leukemia research.

The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Annals of Hematology.

Prevalence and outcomes of uncommon BCR‐ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, British journal of haematology.

Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2016, Medicine.

Molecular Detection of BCR-ABL in Chronic Myeloid Leukemia.

Ya-Zhen Qin, Xiao-jun Huang, Yazhen Qin, 2016, Methods in molecular biology.

Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2013, Leukemia research.

Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes.

Honghu Zhu, Xiao-ying Qin, Yazhen Qin, 2017, Oncology letters.

Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2016, Annals of Hematology.

Bortezomib improves progression‐free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma

B. Jiang, Yan-rong Liu, Y. Lai, 2014, Chinese medical journal.

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Leukemia & lymphoma.

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2022, Frontiers in Oncology.

Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.

Ya-Zhen Qin, Yan-rong Liu, Yu-Hong Chen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.

Yu Wang, Huan Chen, Jin Lu, 2013, Blood.

Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Blood advances.

Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Annals of Hematology.

Comparative Analysis of Flow Cytometry and RQ-PCR for the Detection of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation.

Xiao-hui Zhang, Lanping Xu, Xiao-jun Huang, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation‐negative chronic myeloproliferative disorders detected by a newly developed RQ‐PCR based on TaqMan MGB probes

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Hematological oncology.

Wilms’ tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?

Y. Zuo, Le-ping Zhang, Hong Luo, 2019, Hematology.

PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.

Wen-Min Chen, A. Lu, Le-ping Zhang, 2017, Leukemia research.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

Q. Jiang, B. Jiang, Yan-rong Liu, 2013, Leukemia & lymphoma.

The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2017, Journal of Hematology & Oncology.

Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia

Hao Jiang, Q. Jiang, Yan-rong Liu, 2021, Leukemia & lymphoma.

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.

Hao Jiang, Q. Jiang, B. Jiang, 2013, Leukemia research.

Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the Human Programmed Cell Death 5 Gene 5′ Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese Population

Ya-Zhen Qin, Yan-rong Liu, G. Ruan, 2005, Clinical Cancer Research.

Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia

Lu Yang, F. Dao, Jun Wang, 2021, Scientific Reports.

The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2014, Molecular Cancer.

The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia

Hao Jiang, Q. Jiang, Yan-rong Liu, 2019, Annals of Hematology.

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Leukemia research.

Both Methylation and Copy Number Variation Participated in the Varied Expression of PRAME in Multiple Myeloma

Yan-rong Liu, Wen-Min Chen, Jin Lu, 2020, OncoTargets and therapy.

OTT_A_240979 7545..7553

Ya-Zhen Qin, Yan-rong Liu, Wen-Min Chen, 2020 .

Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics

R. Gale, Hao Jiang, Q. Jiang, 2017, Oncotarget.

PML‐RARA transcript levels at the end of induction therapy are associated with prognosis in non‐high‐risk acute promyelocytic leukaemia with all‐trans retinoic acid plus arsenic in front‐line therapy: long‐term follow‐up of a single‐centre cohort study

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, British journal of haematology.

[The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].

B. Jiang, Yan-rong Liu, G. Ruan, 2013, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity

Ya-Zhen Qin, Yan-rong Liu, Yu Wang, 2013, Annals of Hematology.

Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation

Yu Wang, Xiao-hui Zhang, Lanping Xu, 2020, Medicine.

Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.

Yu-Hong Chen, Yu Wang, Xiao-hui Zhang, 2018, The oncologist.

Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China

Michael L. Wang, S. Parmar, E. Shpall, 2017, Oncotarget.

Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2016, Leukemia research.

Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia

Li-xin Wu, Jing Zhang, Ya-Zhen Qin, 2020, Hematology.

High PRDM16 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk: a comprehensive cohort study from a single Chinese center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2020, Leukemia & lymphoma.

The Clinical Significance and Biological Function of DPEP1 in B-cell Acute Lymphoblastic Leukemia

Jiamin Zhang, Yanmei Xu, R. Gale, 2019, bioRxiv.

S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia

Jiamin Zhang, Li-xin Wu, Jing Zhang, 2019, British journal of haematology.

A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, Leukemia research.

High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy

Hao Jiang, Q. Jiang, Yan-rong Liu, 2018, Medical science monitor : international medical journal of experimental and clinical research.

Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Ya-Zhen Qin, Yu Wang, Xiao-hui Zhang, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.

Ya-Zhen Qin, Yan-rong Liu, Yu-Hong Chen, 2017, Leukemia research.

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.

Q. Jiang, Yan-rong Liu, G. Ruan, 2011, Leukemia research.

Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.

Yan-rong Liu, G. Ruan, Xi Ma, 2006, Leukemia research.

G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr–Abl-induced transformation and leukemogenesis

Ya-Zhen Qin, Weidong Yu, Yulan Liu, 2015, Leukemia & lymphoma.

The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission

Yan-rong Liu, Xiao-hui Zhang, Lanping Xu, 2017, Leukemia & lymphoma.

Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies

Ya-Zhen Qin, Yu-Hong Chen, Yu Wang, 2022, Frontiers in Immunology.

NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2013, Leukemia research.

Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia.

Ya-Zhen Qin, Yan-rong Liu, Y. Lai, 2018, Blood.

In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification.

Ya-Zhen Qin, Yan-rong Liu, Yu Wang, 2014, Blood.

Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2013, Leukemia & lymphoma.

Detecting PML-RARα transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR

B. Jiang, Yan-rong Liu, Honghu Zhu, 2007 .

Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.

B. Jiang, Yan-rong Liu, Honghu Zhu, 2007, Chinese medical journal.

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Yu Wang, Xiao-hui Zhang, Lanping Xu, 2021, BMC cancer.

Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center.

Ya-Zhen Qin, Q. Jiang, Y. Lai, 2020, Clinical lymphoma, myeloma & leukemia.

[Clinical features and prognosis in MLL-AF10 positive acute leukemia].

Xiao-jun Huang, T. Zhao, Shenmiao Yang, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia

Xiao-jun Huang, Honghu Zhu, Yazhen Qin, 2018, Leukemia.

Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor acute lymphoblastic leukemia

Hao Jiang, Ya-Zhen Qin, Q. Jiang, 2022, Cytometry. Part B, Clinical cytometry.

The Prognostic Significance of ZNF384 Fusions in Adult Ph-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: A Comprehensive Cohort Study From a Single Chinese Center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Frontiers in Oncology.

Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.

Yan-rong Liu, G. Ruan, Hong-gang Yu, 2004, Leukemia research.

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Dajun Yang, Q. Jiang, Y. Zhai, 2022, Journal of Hematology & Oncology.

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2008, Annals of Hematology.

Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia

R. Gale, Ya-Zhen Qin, Q. Jiang, 2021, Journal of Cancer Research and Clinical Oncology.

Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.

Ya-Zhen Qin, Q. Jiang, Xiaojun Huang, 2019, The oncologist.

Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2017, Leukemia & lymphoma.

Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis

Lu Yang, F. Dao, Jun Wang, 2020, Scientific Reports.

PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma.

Yan-rong Liu, Wen-Min Chen, Jin Lu, 2017, DNA and cell biology.

[Change of PML/PML-RARalpha protein during treatment with tetraarsenic tetrasulfide (As4S4) in patients with acute promyelocytic leukemia].

Hao Jiang, Yan-rong Liu, L. Bao, 2003, Zhongguo shi yan xue ye xue za zhi.

Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors

Q. Jiang, L. Zuo, Xiaojun Huang, 2019, Annals of Hematology.

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2009, Annals of Hematology.

Subgroup Analysis Can Optimize the Relapse Prediction Cutoff Value for WT1 Expression Following Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia.

Ya-Zhen Qin, Yu Wang, Xiao-hui Zhang, 2019, The Journal of molecular diagnostics : JMD.

Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)

Hao Jiang, Q. Jiang, Yan-rong Liu, 2018, Blood Cancer Journal.

Yan-rong Liu, Xiao-hui Zhang, Xiao-jun Huang, 2009, Leukemia research.

Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21)

Ya-Zhen Qin, Yan-rong Liu, Xiao-jun Huang, 2022, Frontiers in Immunology.

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Blood Cancer Journal.

Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Annals of Hematology.

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

Q. Jiang, Yan-rong Liu, Xiao-hui Zhang, 2019, Cancer medicine.

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Hao Jiang, Q. Jiang, B. Jiang, 2014 .

Resistance to arsenic therapy in acute promyelocytic leukemia.

Ya-Zhen Qin, Xiao-jun Huang, Honghu Zhu, 2014, The New England journal of medicine.

Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL

Hao Jiang, Yi-Lin Wu, Q. Jiang, 2017, Journal of Translational Medicine.

Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment

Ya-Zhen Qin, Hao Jiang, Xiao-jun Huang, 2021, Annals of Hematology.

CXCR4 is a good survival prognostic indicator in multiple myeloma patients.

Ya-Zhen Qin, Q. Jiang, Yan-rong Liu, 2013, Leukemia research.

CD34-Negative is Highly Associated with T (15;17), T (V; 11q23) and theNPM1-Mutation Subtypes in 343 Newly Diagnosed Patients with Acute MyeloidLeukemia

Ya-Zhen Qin, Yan-rong Liu, Honghu Zhu, 2016 .

[Expression of Vascular Endothelial Growth Factor in the Bone Marrow Cells from Adult Chronic Myelogenous Leukemia]

Yan-rong Liu, G. Ruan, Ren-kui Bai, 2001, Zhongguo shi yan xue ye xue za zhi.

The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, Leukemia & lymphoma.

A global study for acute myeloid leukemia with RARG rearrangement

J. Welch, H. Kantarjian, Jiong Hu, 2023, Blood advances.

Correlations between Mutations in Cancer-Related Genes, Therapy Responses and Outcomes of the 3 rd Generation Tyrosine Kinase-Inhibitor (TKI) in Persons with Chronic Myeloid Leukemia Failing Prior TKI-Therapy

R. Gale, Q. Jiang, Xiaojun Huang, 2021, Blood.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

D. Colomer, R. Zadro, N. Cross, 2016, Leukemia.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Hao Jiang, Q. Jiang, B. Jiang, 2015, Leukemia & lymphoma.

Q. Jiang, B. Jiang, Yan-rong Liu, 2012, American journal of hematology/oncology.

Different kinetic patterns of BCR‐ABL transcript levels in imatinib‐treated chronic myeloid leukemia patients after achieving complete cytogenetic response

Hao Jiang, Xiao-jun Huang, G. Ruan, 2008, International journal of laboratory hematology.

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

Hao Jiang, Q. Jiang, B. Jiang, 2014, Bone Marrow Transplantation.

急性T淋巴细胞白血病异基因造血干细胞移植后WT1基因表达及其与预后关系

Yu Wang, Xiao-hui Zhang, Lanping Xu, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, Blood Cancer Journal.

[Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique].

Yan-rong Liu, Xiao-jun Huang, G. Ruan, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China

Michael L. Wang, S. Parmar, E. Shpall, 2017, Oncotarget.

Presence of CD34+CD38−CD58− leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT

Hao Jiang, Q. Jiang, Xiao-jun Huang, 2015, Bone Marrow Transplantation.

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Dajun Yang, Y. Zhai, Yongping Song, 2022, Journal of Hematology & Oncology.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

Q. Jiang, B. Jiang, Yan-rong Liu, 2013, Leukemia & lymphoma.

[Dasatinib treatment based on BCR- ABL mutation detection in imatinib- resistant patients with chronic myeloid leukemia].

Hao Jiang, Q. Jiang, Y. Lai, 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Comparable Efficacy and Safety of Chinese Generic Imatinib and Branded Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Study

Q. Jiang, Y. Lai, Hong-xia Shi, 2019, Blood.

The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Ya-Zhen Qin, Yu Wang, Xiao-hui Zhang, 2018, Annals of Hematology.

Interferon-α may help prevent molecular relapse of chronic myeloid leukemia after the discontinuation of tyrosine kinase inhibitors

Y. Lai, Hong-xia Shi, Xiao-Su Zhao, 2021, Therapeutic advances in hematology.

原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究

Yazhen Qin, Q. Jiang, T. Zhao, 2019, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia

Yan-rong Liu, G. Ruan, Y. Lai, 2020, Annals of Hematology.

Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2012 .

Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes.

Honghu Zhu, Xiao-ying Qin, Yazhen Qin, 2017, Oncology letters.